Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frauke Assmus

Showing results (11-20 of 17) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 17 results.
CPT: Pharmacometrics & Systems Pharmacology|February 9, 2026
Repurposing Oxfendazole for Onchocerciasis: Population Pharmacokinetics of a Tablet Formulation in Healthy African AdultsFrauke Assmus, Ayorinde Adehin, Richard M Hoglund, et al.
Plos Neglected Tropical Diseases|May 13, 2025
Pharmacokinetic-pharmacodynamic modeling of benznidazole and its antitrypanosomal activity in a murine model of chronic Chagas diseaseFrauke Assmus, Ayorinde Adehin, Richard M Hoglund, et al.
Food & Nutrition Research|September 13, 2021
Carbohydrate-dense snacks are a key feature of the nutrition transition among Ghanaian adults - findings from the RODAM studyFrauke Assmus, Cecilia Galbete, Sven Knueppel, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|March 23, 2019
Norbert Wagner, Frauke Assmus, Gabriele Arendt, et al.
Antimicrobial Agents and Chemotherapy|February 18, 2026
Pharmacokinetics, safety, and tolerability of an oxfendazole tablet formulation: a phase 1, randomized, placebo-controlled trial in healthy African volunteersSaid Jongo, Eveline Ackermann, Gloria Nyaulingo, et al.
The Lancet. Microbe|September 11, 2025
Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: a secondary analysis of individual patient data from two proof-of-concept trialsJames A Watson, Cintia Cruz, Fabiana Barreira, et al.
Microorganisms|August 26, 2022
Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19Frauke Assmus, Jean-Sélim Driouich, Rana Abdelnabi, et al.
Pageof 2

Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
CPT: Pharmacometrics & Systems Pharmacology|February 9, 2026
Repurposing Oxfendazole for Onchocerciasis: Population Pharmacokinetics of a Tablet Formulation in Healthy African AdultsFrauke Assmus, Ayorinde Adehin, Richard M Hoglund, et al.
Plos Neglected Tropical Diseases|May 13, 2025
Pharmacokinetic-pharmacodynamic modeling of benznidazole and its antitrypanosomal activity in a murine model of chronic Chagas diseaseFrauke Assmus, Ayorinde Adehin, Richard M Hoglund, et al.
Food & Nutrition Research|September 13, 2021
Carbohydrate-dense snacks are a key feature of the nutrition transition among Ghanaian adults - findings from the RODAM studyFrauke Assmus, Cecilia Galbete, Sven Knueppel, et al.
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz|March 23, 2019
Norbert Wagner, Frauke Assmus, Gabriele Arendt, et al.
Antimicrobial Agents and Chemotherapy|February 18, 2026
Pharmacokinetics, safety, and tolerability of an oxfendazole tablet formulation: a phase 1, randomized, placebo-controlled trial in healthy African volunteersSaid Jongo, Eveline Ackermann, Gloria Nyaulingo, et al.
The Lancet. Microbe|September 11, 2025
Quantifying anti-trypanosomal treatment effects in chronic indeterminate Chagas disease: a secondary analysis of individual patient data from two proof-of-concept trialsJames A Watson, Cintia Cruz, Fabiana Barreira, et al.
Microorganisms|August 26, 2022
Need for a Standardized Translational Drug Development Platform: Lessons Learned from the Repurposing of Drugs for COVID-19Frauke Assmus, Jean-Sélim Driouich, Rana Abdelnabi, et al.
Pageof 2